Item 1A. Risk Factors
ITEM
1A. RISK FACTORS
There
have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December
31, 2023, filed with the SEC on July 24, 2024, except as set forth below.
There
is substantial doubt about our ability to continue as a going concern through the next 12 months from the date of the condensed consolidated
financial statements in this Quarterly Report on Form 10-Q.
The
Company has incurred net losses of $4.5 million and $8.7 million for the three months ended March 31, 2024 and the prior year comparable
period, respectively. For the three months ended March 31, 2024, used in operating activities was $0.1 million, and cash used in
operating activities for the year ended December 31, 2023 was $1.8 million. Based on our cash on hand and working capital at March 31,
2024, we may have insufficient cash to fund planned operations into the third quarter of 2024 . As a result of our losses and our projected
cash needs, combined with our current liquidity level, substantial doubt exists about the Company’s ability to continue as a going
concern over the next 12 months. The recent macroeconomic environment has caused weaker demand than contemplated under the Company’s
business plan, resulting in a reduction in projected revenue and cash flows for the twelve-month period included in the going concern
evaluation.
Our
ability to continue as a going concern is contingent upon successful execution of management’s intended plan over the next twelve
months to improve the our liquidity and profitability, which includes, without limitation:
▪
Further reducing
operating costs expense by taking additional restructuring actions to align cost with revenue
▪
Increasing
revenue by introducing new products and acquiring new customers.
▪
Execute
on strategic partnerships accretive to margins and operating cash
▪
Seeking
additional capital through the issuance of equity securities or obtaining debt financing.
There
can be no assurance that any such measures will be successful. If we are not successful in improving our liquidity position and the profitability
of our operations, we may need to consider all strategic alternatives, including seeking additional debt or equity capital, reducing
or delaying our business activities and strategic initiatives, or selling assets, other strategic transactions and/or other measures,
including receivership or, to the extent available, bankruptcy protection. In addition, the perception that we may not be able to continue
as a going concern may cause vendors and customers to choose not to do business with us due to concerns about our ability to meet our
contractual obligations. If we seek additional financing to fund our operations and there remains substantial doubt about our ability
to continue as a going concern, our financing sources may be unwilling to provide additional funding to us on commercially reasonable
terms or at all. The consolidated financial statements do not include any adjustments that may result from the outcome of this going
concern uncertainty. Such adjustments could be material.
37
We
have failed, and may continue to fail, to meet the listing standards of Nasdaq, and as a result our Class A common stock may become delisted,
which could have a material adverse effect on the liquidity of our Class A common stock.
If
we fail to continue to satisfy the continued listing requirements of Nasdaq, such as the corporate governance or public float requirements,
or the minimum closing bid price requirement, Nasdaq will take steps to de-list our Class A common stock. As a result of several factors,
including but not limited to our financial performance, market sentiment about the cannabis industry, volatility in the financial markets
generally due to the tightening of monetary policy by the Board of Governors of the United States Federal Reserve Bank (the “Federal
Reserve”) and other geopolitical events, events such as the ongoing wars around the world, the per share price of our Class A common
stock has declined below the minimum bid price threshold required for continued listing. Such a de-listing would likely have a negative
effect on the price of our Class A common stock and would impair your ability to sell or purchase our Class A common stock when you wish
to do so, as well as adversely affect our ability to issue additional securities and obtain additional financing in the future.
On
August 21, 2023, we received a letter from the staff of Nasdaq indicating that we were not in compliance with Nasdaq Listing Rule 5450(a)(1)
because the closing bid price per share for our Class A common stock had closed below $1.00 for the previous 30 consecutive business
days (the “Minimum Bid Price Requirement”). We were given 180 days, or until February 20, 2024 to regain compliance with
the Minimum Bid Price Requirement. We also filed an application to transfer the listing of our Class A common stock from the Nasdaq Global
Market to the Nasdaq Capital Market, which transfer was approved and occurred on February 9, 2024. As a result of the transfer, we became
eligible to request an additional an additional 180-day compliance period.
On
February 21, 2024, Nasdaq notified us in writing that while we had not regained compliance with the Minimum Bid Price Requirement, we
were eligible for an additional 180-day compliance period, or until August 19, 2024, to regain compliance with the Minimum Bid Price
Requirement. Nasdaq’s determination was based on us having met the continued listing requirement for market value of publicly held
shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid
Price Requirement, and on our written notice to Nasdaq of our intention to cure the deficiency during the second compliance period by
effecting a reverse stock split, if necessary.
If
we do not regain compliance during the second 180-day period, then Nasdaq will notify us of its determination to delist our Class A common
stock, at which point we would have an opportunity to appeal the delisting determination to a hearings panel. We would remain listed
on Nasdaq pending the hearings panel’s decision. There can be no assurance that, if we do appeal the delisting determination by
Nasdaq to the hearings panel, that such appeal would be successful.
On
January 24, 2024, Gina Collins gave notice of her resignation from our Board of Directors and from each committee of the Board, effective
immediately. Ms. Collins was an independent director, and as a result of her resignation, we no longer comply with the majority independent
board requirement of Nasdaq as set forth in Nasdaq Listing Rule 5605(b)(1) because independent directors do not comprise a majority of
the Board of Directors, and Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rule 5605(c)(2)(A) because the
Audit Committee of the Board of Directors is not comprised of at least three independent directors.
On
January 29, 2024, in accordance with Nasdaq Listing Rules, we notified Nasdaq of Ms. Collins’ resignation and the resulting non-compliance.
On January 30, 2024, we received a notice from Nasdaq acknowledging the fact that we do not meet the requirements of such rules. In accordance
with Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4), to regain compliance with the Nasdaq Listing Rules, we have until the earlier
of our next annual stockholders meeting or January 24, 2025.
On
April 18, 2024, we received a notice from Nasdaq stating that because we had not yet filed our Annual Report on Form 10-K for the fiscal
year ended December 31, 2023, we were no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires
listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.
On
May 21, 2024, we received a notice from Nasdaq stating that because we had not yet filed our Quarterly Report on Form 10-Q for the fiscal
quarter ended March 31, 2024, we were no longer in compliance with Nasdaq Listing Rule 5250(c)(1).
The
Company had 60 calendar days from April 18, 2024, or until June 17, 2024, to regain compliance
by filing the Form 10-K and the Form 10-Q or to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules.
We timely submitted the plan to regain compliance to Nasdaq and Nasdaq granted us additional time to file the Form 10K and 10Q and with
this filing will have filed both the 10K and 10Q within the additional time period granted.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.